Disc Medicine (IRON) Non-cash Items (2021 - 2025)
Disc Medicine (IRON) reported Non-cash Items of $1.7 million for Q4 2025, down 98.37% year-over-year from $106.8 million in Q4 2024, and down 98.37% on a QoQ basis from $106.8 million in Q4 2024.
Disc Medicine (IRON) has 5 years of Non-cash Items data on file, last reported at $1.7 million in Q4 2025.
- Quarterly Non-cash Items fell 98.37% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 98.37% YoY) and the FY2025 annual result came in at $1.7 million, down 98.37% from the prior year.
- Non-cash Items declined to $1.7 million in Q4 2025 per IRON's latest filing, from $106.8 million in the prior quarter.
- Across five years, Non-cash Items topped out at $114.4 million in Q1 2024 and bottomed at $1.0 million in Q1 2023.
- The 5-year median for Non-cash Items is $80.4 million (2024), against an average of $63.0 million.
- The widest annual swing landed in 2024, when Non-cash Items jumped 11082.64%; it then slumped 98.37% in 2025.
- Tracing IRON's Non-cash Items over 5 years: stood at $13.0 million in 2021, then soared by 95.85% to $25.5 million in 2022, then jumped by 327.54% to $109.1 million in 2023, then fell by 2.12% to $106.8 million in 2024, then tumbled by 98.37% to $1.7 million in 2025.
- Per Business Quant, the three latest IRON Non-cash Items figures stand at $1.7 million (Q4 2025), $106.8 million (Q4 2024), and $80.4 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | 106.77 Mn |
| Dec 31, 2024 | 106.77 Mn |
| Sep 30, 2024 | 80.42 Mn |
| Sep 30, 2024 | 80.42 Mn |
| Jun 30, 2024 | 72.72 Mn |
| Jun 30, 2024 | 72.72 Mn |
| Mar 31, 2024 | 114.37 Mn |
| Mar 31, 2024 | 114.37 Mn |
| Dec 31, 2023 | 109.08 Mn |
| Dec 31, 2023 | 109.08 Mn |
| Sep 30, 2023 | 86.19 Mn |
| Sep 30, 2023 | 86.19 Mn |
| Jun 30, 2023 | 82.59 Mn |
| Jun 30, 2023 | 82.59 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 25.51 Mn |
| Dec 31, 2022 | 25.51 Mn |
| Dec 31, 2021 | 13.03 Mn |
| Dec 31, 2021 | 13.03 Mn |